Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB. by De Bentzmann, Sophie et al.
Unique biofilm signature, drug susceptibility and
decreased virulence in Drosophila through the
Pseudomonas aeruginosa two-component system PprAB.
Sophie De Bentzmann, Caroline Giraud, Christophe Bernard, Virginie
Calderon, Friederike Ewald, Patrick Ple´siat, Cathy Nguyen, Didier Grunwald,
Ina Attree, Katy Jeannot, et al.
To cite this version:
Sophie De Bentzmann, Caroline Giraud, Christophe Bernard, Virginie Calderon, Friederike
Ewald, et al.. Unique biofilm signature, drug susceptibility and decreased virulence in
Drosophila through the Pseudomonas aeruginosa two-component system PprAB.. PLoS




Submitted on 15 Nov 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

Unique Biofilm Signature, Drug Susceptibility and
Decreased Virulence in Drosophila through the
Pseudomonas aeruginosa Two-Component System
PprAB
Sophie de Bentzmann1.*, Caroline Giraud1", Christophe S. Bernard1", Virginie Calderon2,
Friederike Ewald1, Patrick Ple´siat3, Cathy Nguyen4, Didier Grunwald5, Ina Attree5, Katy Jeannot3, Marie-
Odile Fauvarque6, Christophe Bordi1.
1 Laboratoire d’Inge´nierie des Syste`mes Macromole´culaires, CNRS - Aix Marseille University, Marseille, France, 2Universite´ de Toulouse, UPS, Laboratoire de Microbiologie
et Ge´ne´tique Mole´culaire, Toulouse, France, and CNRS, LMGM, Toulouse, France, 3 Laboratoire de Bacte´riologie, Faculte´ de Me´decine-Pharmacie, Universite´ de Franche-
Comte´, Besanc¸on, France, 4 TAGC U928 case 928, Marseille, France, 5CNRS ERL5261 ‘‘Bacterial Pathogenesis and Cellular Responses,’’ CEA, iRTSV, Biologie du Cancer et de
l’Infection, Grenoble, France and INSERM, UMR-S 1036, Grenoble, France and UJF-Grenoble I, UMR-S 1036, Grenoble, France, 6CEA, iRTSV, Biologie a` Grande Echelle,
Grenoble, France and INSERM, U1038, Grenoble, France and UJF-Grenoble I, U1038, Grenoble, France
Abstract
Bacterial biofilm is considered as a particular lifestyle helping cells to survive hostile environments triggered by a variety of
signals sensed and integrated through adequate regulatory pathways. Pseudomonas aeruginosa, a Gram-negative bacterium
causing severe infections in humans, forms biofilms and is a fantastic example for fine-tuning of the transition between
planktonic and community lifestyles through two-component systems (TCS). Here we decipher the regulon of the P.
aeruginosa response regulator PprB of the TCS PprAB. We identified genes under the control of this TCS and once this
pathway is activated, analyzed and dissected at the molecular level the PprB-dependent phenotypes in various models. The
TCS PprAB triggers a hyper-biofilm phenotype with a unique adhesive signature made of BapA adhesin, a Type 1 secretion
system (T1SS) substrate, CupE CU fimbriae, Flp Type IVb pili and eDNA without EPS involvement. This unique signature is
associated with drug hyper-susceptibility, decreased virulence in acutely infected flies and cytotoxicity toward various cell
types linked to decreased Type III secretion (T3SS). Moreover, once the PprB pathway is activated, decreased virulence in
orally infected flies associated with enhanced biofilm formation and dissemination defect from the intestinal lumen toward
the hemolymph compartment is reported. PprB may thus represent a key bacterial adaptation checkpoint of multicellular
and aggregative behavior triggering the production of a unique matrix associated with peculiar antibiotic susceptibility and
attenuated virulence, a particular interesting breach for therapeutic intervention to consider in view of possible eradication
of P. aeruginosa biofilm-associated infections.
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Introduction
Almost all bacterial species can live in sessile communities called
biofilms. Biofilms are a particular problem for human health, not
only because they may cause several infectious diseases, but
because they are associated with many inert surfaces, including
those of medical devices for internal or external use [1] and are
very difficult to eradicate. Moreover, their associated existence
with infections is probably underestimated, principally due to the
need for in vivo diagnosis [2]. A common property of biofilms is the
presence of a matrix surrounding the community, shaping and
protecting it, as well as, immobilizing its members. This auto-
produced matrix is mainly composed of exopolysaccharides (EPS),
proteins (soluble and parietal mostly assembled into structures
such as fimbriae, pili and flagella), lipids and DNA, forming a
hydrated polymer, the composition of which could be greatly
influenced by the species forming the community as well as by
environmental conditions [3]. Biofilm formation is a dynamic
process passing through a four-stage universal growth cycle
consisting of initiation (attachment of planktonic cells to the
substrate), maturation, maintenance, and dissolution (these three
being considered as post-attachment) phases. The transition
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between planktonic and community lifestyles in bacteria is tightly
regulated and depends on environmental signals that the bacteria
integrate to unfold the most appropriate response. This requires a
complex regulatory network including two-component systems
(TCS), transcriptional regulators, quorum sensing and post-
transcriptional regulatory mechanisms [1]. Among them, the
TCSs represent a predominant signaling mechanism in bacteria
and are formed of a histidine kinase (HK) and a response regulator
(RR) in the simplest and termed classical form.
Pseudomonas aeruginosa, a Gram-negative bacterium that causes
severe infections in humans, can infect non-mammalian hosts by
using similar virulence mechanisms as in mammalian models [4–
7]. P. aeruginosa forms biofilms and is a fantastic example for fine-
tuning of the transition between planktonic and community
lifestyles through TCSs. The P. aeruginosa PAO1 genome sequence
possesses 63 HK and 64 RR [8], with additional copies identified
in newly sequenced genomes [9,10]. Among them, a substantial
number has been demonstrated to be involved in community
lifestyle or in the transition between planktonic and community
lifestyles. The molecular switch executed by the three sensors
RetS/GacS/LadS is a good example of such a regulatory
mechanism involving small RNAs RsmY and RsmZ. Although
the GacSA TCS and the hybrid HK LadS [11] are activating
biofilm formation and negatively regulating Type III secretion
system (T3SS)-dependent cytotoxicity through sRNA expression,
GacS is antagonized by the hybrid HK RetS [12]. Whereas RetS/
LadS/GacS pathway controls RsmY and RsmZ sRNAs, the HptB
signaling pathway acts solely on RsmY production and positively
regulates biofilm and negatively T3SS-dependent cytotoxicity
[13]. Further post-attachment reduction of rsmZ RNA level in
biofilms, is dependent on another TCS BfiSR, which directly
regulates expression of the cafA gene encoding RNase G acting on
RsmZ stability [14]. BfiSR belongs to the three novel P. aeruginosa
TCSs essential in regulating the transition to irreversible
attachment (BfiSR, stage 1–2), maturation-1 (BfmSR, stage 2–3),
and maturation-2 (MifSR, stage 3–4) during biofilm development
[15]. Beside those TCSs implicating sRNA, other TCSs like the
Roc1 [16] and Roc2 [17] and the four player PvrRS/RcsBC
TCSs [18], probably act on the control of the intracellular levels of
c-di-GMP and on fimbrial gene expression of the chaperone-usher
(CU) systems CupB, CupC and CupD [19], respectively. The
Pseudomonas (membrane) Permeability Regulator (PprB) gene
encodes the RR of the classical TCS PprAB, with its cognate HK
PprA. The PprB RR is a member of the NarL/LuxR family, with
a receiver domain and a DNA-binding, helix-turn-helix (HTH)
domain. It was first identified as involved in the increased
permeability of the P. aeruginosa membrane to various antibiotics in
the PAK genetic background [20]. It was interestingly character-
ized as controlling directly and positively the expression of two
molecular systems helping this bacterium to form biofilm [21],
which are Type IVb Flp pili [22] and CU CupE fimbriae [23].
The present study was dedicated to the determination of the
PprB regulon using transcriptomic analysis. From the common
target genes differentially regulated in the strain overproducing
PprB versus the pprB mutant, we identified a limited number of
genes that we then validated using transcriptional fusions, RT-
qPCR and electrophoretic mobility shift assay (EMSA) approach-
es. Among them, we identified genes encoding a Type 1 secretion
system (T1SS) secreting an adhesin BapA, and the Pseudomonas
quinolone signal (PQS) system. The molecular analysis of the
global behavior associated with the activation of the PprB pathway
was further conducted. Beside in vitro flow cell and cellular models,
we tested the contribution of the PprB pathway to in vivo biofilm
formation and bacterial virulence in Drosophila melanogaster flies. In
this model, septic injury provokes death by septicemia in a day,
mimicking an acute infection whereas virulent bacteria present in
contaminated food induce gut chronic infection and death in
several days by crossing the gut epithelial barrier and invading the
hemocoele [24–27].
Under PprB-activated pathway conditions, hyper-biofilm phe-
notype relied on a unique combination of Type IVb pili, CupE
fimbriae, BapA adhesin and eDNA rather than on Pel and Psl, the
two major EPS of non-mucoid strains. Activation of the PprB
regulatory pathway is associated with drug hyper susceptibility
particularly in biofilms and attenuated virulence in both acute and
chronic Drosophila infection models. Thus, the response regulator
PprB is a new player of the key regulators of P. aeruginosa
participating to the transition between planktonic and community
lifestyles.
Results
Activation of a TCS regulatory pathway can be frequently
assumed by overexpression of the RR gene onto a replicative
plasmid. Determination of the PprB regulon was thus performed
using comparison of transcriptomic profiles of the PAO1attB::cupE-
lacZ strain carrying the empty vector pMMB67-HE (reference
condition) and of the PAO1attB::cupE-lacZ strain carrying the
pMMBpprB vector (inducing condition) (Experiment 1), and of the
PAO1DpprBattB::cupE-lacZ strain (reference condition) and of the
PAO1attB::cupE-lacZ strain (inducing condition) (Experiment 2).
To override the requirement for antibiotic use to maintain
plasmids in phenotypic analysis, all experiments aiming at the
characterization of the PprB-dependent phenotypes were further
conducted in the PprBK (PAO1LBTn10) [23] genetic background.
This strain was obtained in a previous wide-genome transposon
mutagenesis conducted to obtain cupE regulators. It possesses the
Mariner transposon located upstream from the fppA gene, with the
internal ptac promoter driving the expression of downstream pprB
gene, as checked by RT-qPCR. We checked that in this strain,
target genes overlap the ones presented in Experiment 1 (data not
shown).
Author Summary
We unraveled that once the two-component system PprAB
regulatory pathway is activated, Pseudomonas aeruginosa
displays a unique hyper-biofilm phenotype due to a
molecular signature combining a T1SS high molecular
weight substrate, BapA, fimbriae of the chaperone-usher
pathway, Type IVb pili and eDNA. Originally, this particular
hyper-biofilm that is not strictly dependent on Psl or Pel
exopolysaccharide (EPS) synthesis displays increased drug
susceptibility, in contrary to previously reported biofilm
lifestyle associated with increased resistance to antibiotics.
PprB-dependent hyper-biofilm was also observed on
intestinal mucosa of orally infected Drosophila flies in
which it also displays a reduced capacity to cross the
epithelial barrier from the intestinal lumen toward the
hemolymph that consequently resulted in a reduced
capacity to kill flies. Furthermore, constitutive activation
of this PprB regulatory pathway triggers a reduced
secretion of T3SS effectors which may account for the
decreased virulence observed in epithelial and macro-
phage lineages and in acute Drosophila infections induced
by septic injury. We appended in this study pieces of
regulatory and molecular data that highlight the possibility
to combat infections due to P. aeruginosa-biofilm with
particular matrix.
PprB Regulatory Pathway in P. aeruginosa
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Analysis of transcriptional profiles
In order to identify new genes potentially regulated by the TCS
PprAB, we designed MGPA arrays (Agilent) (see supplemental
experimental procedures) and carried out microarray experiments.
Specific genome-wide expression profiles were obtained in two sets
of experiments as described above. Applying selective criteria (see
Supplemental experimental procedures), 130 and 56 genes (see
supplementary Tables S1 and S2) were found to be differentially
expressed in Experiments 1 and 2, respectively. To focus on genes
belonging to the PprB regulon, genes conversely expressed in
common in these two sets of experiments were selected after
intensive analytical treatment and a final list of 35 genes has been
established (Table 1). Among them, 18 belong to the flprcptad (13)
and the cupE (5) loci already described to be under the direct
control of the TCS PprAB [22,23], a result which validated our
approach (Fig. S1). The flprcptad locus refers to a DNA region
constituted of five transcriptional units that encodes the Flp Type
IVb pilus assembly machinery and contains the pprA and pprB
genes, the two tcs genes positively regulating all the other genes
encoding the pilus machinery [22].
Seventeen new candidates belonging to 6 different loci were
identified (Fig. S1) including i/ the pqsA-phnA locus involved in the
production of PQS, ii/ the PA1221-1210 locus encoding proteins
of unknown functions, iii/ the PA1874-1877 locus which encodes a
Table 1. List of genes commonly and conversely regulated in microarray experiments (1 : PAO1attB::cupE-lacZ/pMMBpprB strain vs
PAO1attB::cupE-lacZ/pMMB67HE strain, 2 : PAO1attB::cupE-lacZ strain vs PAO1DpprBattB::cupE-lacZ strain).
PA number





PA0998 Q9I4X1 Homologous to beta-keto-acyl-acyl-carrier protein synthase PqsC +3.45 23.27
PA0999 P20582 3-oxoacyl-[acyl-carrier-protein] synthase III PqsD +4.02 23.6
PA1000 P20581 Quinolone signal response protein PqsE +3.66 23.43
PA1001 P09785 Anthranilate synthase component I PhnA +3.74 23.45
PA1002 P09786 Anthranilate synthase component II PhnB +3.59 23.4
PA1213 Q9I4C5 putative clavaminic acid synthetase +2 22.2
PA1214 Q9I4C4 Putative sparagine synthase +2.16 22.59
PA1216 Q9I4C2 Hypothetical protein +2.39 22.15
PA1217 Q9I4C1 Probable 2-isopropylmalate synthase +2.39 22.53
PA1218 Q9I4C0 Hypothetical protein +2.21 22.6
PA1874 Q9I2M3 Large uncharacterized protein BapA +25.72 212.64
PA1875 Q9I2M2 Probable outer membrane protein of T1SS transporter BapB +28.81 29.17
PA1876 Q9I2M1 probable ATP-binding protein of T1SS transporter BapC +19.53 26.41
PA1877 Q9I2M0 probable fusion protein of T1SS transporter BapD +16.94 27.11
PA1914 Q9I2J0 HvnA +31.86 23.87
PA3662 Q9HXX7 Hypothetical protein 29.5 +3.73
PA4293 Q9HWA7 Histidine kinase PprA +11.5 24.45
PA4294 Q9HWA6 Pseudopilin TadF +15.68 24.04
PA4296 Q9HWA4 Response regulator PprB +32.23 238.5
PA4297 Q9HWA3 TadG +3.86 220.24
PA4298 Q9HWA2 Hypothetical protein +4.35 210.76
PA4299 Q9HWA1 TadD +5.13 216.84
PA4300 Q9HWA0 PilC-like protein TadC +5.51 215.8
PA4301 Q9HW99 PilC-like protein TadB +4.46 211.05
PA4302 Q9HW98 ATPase TadA +5.49 219.17
PA4303 Q9HW97 TadZ +4.36 29.95
PA4304 Q9HW96 Secretin RcpA +5.33 213.45
PA4305 Q9HW95 RcpC +5.33 217
PA4306 Q9HW94 Pilin subunit Flp +5.6 239
PA4648 Q9HVE4 Fimbrial subunit CupE1 +5.67 27.03
PA4649 Q9HVE3 Fimbrial subunit CupE2 +7.98 211.85
PA4650 Q9HVE2 Fimbrial subunit CupE3 +6.75 27.45
PA4651 Q9HVE1 Chaperone CupE4 +7.74 211.7
PA4652 Q9HVE0 Usher CupE5 +2.12 23.53
PA5287 Q9HTR7 Ammonium transporter AmtB +2.28 22.21
afold changes correspond to mean values of the four replicates performed for each condition.
doi:10.1371/journal.ppat.1003052.t001
PprB Regulatory Pathway in P. aeruginosa
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large uncharacterized protein and a T1SS transporter described as
involved in antibiotic resistance [28], that we renamed bapABCD
locus, iv/ the PA1914 gene encoding a putative homologue of
HvnA protein of Vibrio fischeri [29], that we renamed hvnA, v/ the
PA3662 gene encoding a protein with unknown function and vi/
the PA5287 gene encoding the ammonium transporter AmtB,
forming an operon with the gene glnK encoding the nitrogen
regulatory protein P-II 2. All these new identified genes, except
PA3662, were positively regulated by the RR PprB (upregulated
under PprB overproduction conditions and downregulated in the
pprB mutant).
Validation of target genes
pqsABCDE, phnAB, PA1221-PA1216, PA1215-PA1211 loci,
PA3662 and amtB genes found to be differentially regulated in
transcriptomic experiments were further analyzed. The corre-
sponding chromosomal transcriptional fusions (pqsA-lacZ, phnA-
lacZ, PA1215-lacZ, PA1221-lacZ and gnlK-lacZ) were introduced
into the PAO1 wild type strain (carrying pMMB67HE or
pMMBpprB vectors). Additionally, the pqsA-lacZ and the PA3662-
lacZ fusions were introduced into the pprB mutant PAO1DpprB
(carrying pMMB67HE or pMMBpprB). The pqsA-lacZ fusion was
moderately but significantly induced in pprB-overexpressing
conditions and down-regulated in the pprB mutant (Fig. 1A). An
eight-fold increase in the levels of pqsA transcripts upon PprB
overproduction (data not shown) observed by RT-qPCR fully
confirmed this PprB-dependent effect on pqs gene expression. The
activity of the PA3662-lacZ fusion was found to be significantly
derepressed in the pprB mutant as compared to the wild type strain
(Fig. 1C) and restored to the wild-type strain level when the pprB
gene was brought in trans, fully confirming that this gene is under
the negative control of the RR PprB. Using EMSA with a
functional PprB-6His protein (see supplemental experimental
procedures and Fig. S7), it appeared that the PprB-dependent
control of PA3662 and pqs genes was indirect (Fig. 1B and 1D),
whereas in the same conditions, PprB-6His is able to bind to the
cupE promoter (data not shown). None of the other fusions was
responsive to pprB overexpression as illustrated for phnA-lacZ (Fig.
S2A), PA1215-lacZ (Fig. S2B), PA1221-lacZ (Fig. S2C) and glnK-
lacZ (Fig. S2D) fusions. We thus confirmed that the TCS PprAB
exerts an indirect and positive while moderate but significant
control on the pqs biosynthetic operon and an indirect but negative
control on the PA3662 gene.
Halovibrin-like protein
Among the targets positively regulated by the TCS PprAB, the
gene PA1914, renamed hvnA for Halovibrin A (see latter), was one
of the most activated genes with a <30-fold induction. The hvnA-
lacZ fusion although exhibiting a significant level in the wild type
strain, was further induced in pprB-overexpressing conditions and
down-regulated in the pprB mutant (Fig. 1E). Using EMSA, the
DNA region of 630 bp encompassing the hvnA putative promoter
was not retarded in the presence of the PprB-6His protein (Fig. 1F).
Thus, the TCS PprAB positively but indirectly controls expression
of the hvnA gene. The hvnA gene encodes a putative protein sharing
44% of identity with the two HvnA and HvnB proteins from Vibrio
fischeri (Fig. S3A). It contains a putative NADase domain (an
indirect ADP-ribosyltransferase (ARTase) activity leading to free
ADP-ribose). However, in contrast to T3SS effectors possessing an
ARTase activity that contribute to Drosophila fast killing [26],
HvnA was not required for full virulence in Drosophila acute model
of infection in the PAO1 genetic background (Fig. S3B) or in the
PprBK genetic background (data not shown).
A new large cell surface and secreted adhesion
Among the common targets identified in the two sets of
microarray experiments is also the PA1874-1877 gene locus. This
locus of 4 genes forms a putative operon. Using appropriate
overlapping oligonucleotides, we revealed that the four genes are
transcribed as a polycistronic mRNA (Fig. S4A). Due to our
findings (see latter), these genes in P. aeruginosa have been renamed,
bapA, bapB, bapC and bapD for PA1874, PA1875, PA1876 and
PA1877, respectively. The bapA-lacZ fusion displayed a strict PprB-
dependent expression (Fig. 2A) since it exhibited a rather null
activity in the pprB mutant as well as in the wild type strain and
bapA gene expression was significantly induced by the overpro-
duction of the RR PprB, confirming the positive PprB regulation
observed in microarray experiments. Using EMSA, the DNA
region of 329 bp encompassing the putative promoter of bap genes
formed at least two retarded complexes with PprB-6His concen-
trations higher than 0.34 mM (Fig. 2B). Thus, the TCS PprAB
positively and directly controls expression of the bap gene locus.
The P. aeruginosa putative BapA protein for biofilm-associated
protein A (2464 aa) is characterized by the absence of any peptide
signal and by a two-domain organization (Fig. 2C), reminiscent of
the LapA proteins of P. fluorescens WCS365 [30] and of P. putida
KT2440 [31], of the LapF protein of P. putida KT2440 [32] and of
the BapA protein of S. enterica [33]. The BapA protein of PAO1
strain consists of two domains, Domain 1of 3 and Domain 2 of 18
repeats of 82 and 86 aa, respectively (Fig. 2C). A lot of sequence
variations could be observed in the corresponding putative
proteins in the different P. aeruginosa genomes examined (see
supplemental informations, Fig. S4B). The other P. aeruginosa
putative Bap proteins are predicted to be an ATP-binding cassette
(ABC) transporter formed of an ATPase of 723 aa (PA1876 or
BapC protein), a membrane fusion protein of 395 aa (PA1877 or
BapD protein) and an outer membrane (OM) protein of 425 aa
(PA1875 or BapB protein). This transporter has been shown to
participate in a biofilm-specific resistance mechanism involving
efflux of drugs including tobramycin but also linked to ndvB-
derived glucan mechanism [28]. Thus, this system unequivocally
forms a T1SS transporter, potentially responsible for the export of
the associated large protein BapA, a new member of large
externalized, repeat-rich proteins emerging as important factors in
the attachment of bacteria to biotic and abiotic surfaces [34,35],
that could be predicted to function as an adhesin. We therefore
investigated the localization of BapA and its BapBCD-dependent
secretion. Since no BapA production was observable in the PAO1
genetic background (Fig. 2D), further experiments were conducted
in the PprBK genetic background. In this strain, we detected a
strong production of BapA in total cell extracts, which migrates at
an apparent molecular weight around 260 kDa (Fig. 2D), a
specific signal that was further assessed by the absence of BapA
protein in the bapA mutant. BapA was not detected in the same
samples derived from the bapD mutant (Fig. 2D), suggesting that in
the absence of one element of the transporter, here BapD, the
substrate BapA is unstable, and that BapD could participate to
BapA stabilization. We further checked where it localized. BapA
was not associated with membranes (M), but recovered in classical
supernatant (S1) as well as associated loosely with the cell surface
and therefore can be removed from the OM using quick and
gentle vortexing procedure, since it was also recovered in the
second supernatant (S2) (Fig. 2E).
PprB dependent phenotypes
To define a general view of PprBK strain behavior, biofilm
formation in flow cell, drug susceptibility, cytotoxicity toward
PprB Regulatory Pathway in P. aeruginosa
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Figure 1. Validation of pqs, PA3662 and hvnA genes. Expression of chromosomal pqsA-lacZ (A), PA3662-lacZ (C) and hvnA-lacZ (E) fusions was
monitored in the PAO1/pMMB67HE, PAO1DpprB/pMMB67HE, PAO1/pMMBpprB and PAO1DpprB/pMMBpprB strains. Data are expressed in Miller units
and correspond to mean values (with error bars) obtained from three or six independent experiments. Statistical analysis was performed using a
Welch (C and E) or a t-test (A) (*:,0.05, **:,0.01, ***:,0.001). EMSAs performed with the purified PprB-6His protein, at concentrations of 0 to
2.34 mM, and the putative pqs (B), PA3662 (D), and hvnA (F) promoter DNA regions.
doi:10.1371/journal.ppat.1003052.g001
PprB Regulatory Pathway in P. aeruginosa
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Figure 2. Validation of bap genes. Expression of the chromosomal bapA-lacZ fusion ( ) was monitored in the PAO1/pMMB67HE, PAO1DpprB/
pMMB67HE, PAO1/pMMBpprB and PAO1DpprB/pMMBpprB strains. Data are expressed in Miller units and correspond to mean values (with error bars)
obtained from three independent experiments. Statistical analysis was performed using a Welch test (*:,0.05). EMSA (B) performed with the purified
PprB-6His protein, at concentrations of 0 to 2.34 mM, and the putative bap promoter DNA region. Two retarded complexes (upper arrows) were
identified at high PprB-6His concentrations. BapA protein from P. aeruginosa is a 2468 aa polypeptide (C) organized into two domains of 3 (Domain
1) and 18 (Domain 2) repeats of 82 and 86 aa, respectively. BapA production was detected (D) in western blot in the total cell extracts obtained from
PAO1, PprBK, PprBKDbapA, and PprBKDbapD strains. As a control of equivalent loading between strains, OTCase protein was detected in the same
samples. Number on left side is molecular weight standard (kDa). BapA localization (E) was checked in soluble (cytoplasmic and periplasmic fractions),
in membrane (M) fractions, in classical (S1) and associated loosely with the cell surface (S2) supernatants. Cell leakage was specifically detected using
anti-OTCase antibody.
doi:10.1371/journal.ppat.1003052.g002
PprB Regulatory Pathway in P. aeruginosa
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A  
eukaryotic cell lines (HeLa and J774) and virulence in flies were
examined.
The PprBK strain displayed a peculiar hyper-biofilm pheno-
type, allowing cells to gather in microcolonies as soon as day one
(J1) of biofilm development with significant three dimensional
expansion while at the same time point the PAO1 strain formed a
single layered-cell carpet on the glass substrate (Fig. 3A). This was
indeed much more observable after four days (J4), where the
PprBK strain was forming three dimensional mushrooms two-fold
higher than the PAO1 strain (roughly 200 mm for the PprBK as
compared to 80 mm for the PAO1 strain). Unexpectedly, PprBK
was two-fold more susceptible to tobramycin in particular under
biofilm growth conditions as compared to PAO1 strain in a very
reproducible manner (Table S3). Concordant with these results,
the number of dead cells observed was strongly increased in the
PprBK biofilms as compared to the PAO1 biofilms after exposure
to tobramycin (Fig. 3B). Whereas centers of mushrooms contained
live bacteria in the PAO1 formed biofilm, they were always
containing a majority of dead cells in the PprBK one. Additionally,
whereas susceptibility to tobramycin was restricted to the
superficial layer of the PAO1 - formed biofilms, it has reached
in depth cells of the PprBK formed biofilm (Fig. 3B, left panel).
This result was confirmed by the quantitative resazurin test in
which PprBK - formed biofilms exhibited a significantly reduced
viability as compared to PAO1 - formed biofilms (Fig. 3B, right
panel).
Characterization of the PprB-dependent virulence was then
assayed in D. melanogaster and compared to the one of the PAO1
strain. When introduced in flies by septic injury to produce acute
infection, the PprBK strain was found to be strongly attenuated in
virulence (Fig. 3C), with LD50 reached after 18 hr and 28 hr of
infection, in PAO1 and PprBK strains, respectively. Since, fast
Drosophila killing has been mainly associated with T3SS activity
[5,26], we then compared the capacity of the PprBK strain to
induce cytotoxicity on cultured epithelial HeLa cells and murine
macrophage J774 cell line. In both assays, compared to the PAO1
strain, PprBK was clearly found less cytotoxic with delayed effects
on LDH release measured for infected macrophages and cell
rounding of HeLa cells (Fig. 3D, left panel; upper and right panel).
In concordance with cellular effects, PprBK secreted significantly
less T3SS proteins, namely PcrV, PopB and PopD in culture
supernatants (Fig. 3D, right and lower panel), further arguing that
reduced virulence of the PprBK strain in acutely infected Drosophila
can be attributed to reduced T3SS activity.
Drosophila can also be orally infected mimicking a chronic model
of infection. The hyper-biofilm P. aeruginosa strain (PAZH) has
been recently reported to produce reduced virulence in both
acutely and chronically infected flies [24]. Interestingly, the PprBK
strain was also found to be strongly attenuated in virulence in
orally infected flies (Fig. 3E), as compared to the PAO1 strain.
Moreover, the PAO1 strain was detected in the hemolymph two
days post infection and the total average amount reached
<200 CFU/fly three days post infection, while PprBK strain
was barely detected in the hemolymph at day 3 with repeatedly
less than 50 CFU/fly collected (Fig. 3F, p= 0.041). Deletion of
bapA gene did not alter virulence as compared to its isogenic
parental strain PprBK (Fig. 3E) and did not restore the capacity of
the PprBK strain to cross the digestive barrier (Fig. 3F). These
results indicate that decreased PprB-dependent virulence is tightly
associated with dissemination defect through the Drosophila
digestive barrier. This suggests that secreted molecules produced
in PprBK other than BapA may prevent dissemination, and/or
that products of some genes repressed in the PprBK context are
required to cross the epithelial barrier.
Taken together, these results are in favor with a TCS PprAB
dependent hyper-biofilm phenotype associated with decreased
virulence in acute and chronic cell or animal models and drug
hyper-susceptibility.
BapA, Type IVb pili, CU fimbriae and eDNA contribute to
the PprB-dependent biofilm phenotype
We further examined whether BapA could be a potential new
adhesin playing a role in P. aeruginosa biofilm formation. The single
mutants PprBKDbapA and PprBKDbapD displayed an altered
biofilm phenotype as compared to the isogenic parental strain
PprBK (Fig. 4A), thus confirming that BapA is strongly involved in
the PprBK hyper-biofilm phenotype and that BapA is an adhesin
exported by the T1SS BapBCD transporter. Additionally,
PprBKDcupE5 and PprBKDflp mutants displayed altered mush-
room structures (Fig. 4A) in a rather identical manner than did the
PprBKDbapA mutant, with poorly packed microcolonies that had
not expanded in 3D and were not forming mushroom-shaped
structures. Additional triple mutation was generated in this strain,
thus leading to the PprBKDcupE5DbapADflp strain, which
displayed a very similar phenotype to any of the single mutants
(Fig. 4A), suggesting that CupE CU fimbriae, Flp Type IVb pili,
and BapA adhesin all cooperate in the PprBK hyper-biofilm
phenotype and that absence of any of them strongly destabilizes
the biofilm formed. Since no particular EPS genes (pel, psl, alg)
have been identified as controlled by the TCS PprAB (Tables S1
and S2) and additionally confirmed by RT-qPCR (data not
shown), we investigated whether any of the exopolysaccharides Pel
or Psl associated with non mucoid phenotype contribute to the
PprBK hyper-biofilm phenotype, PprBK having a non mucoid
phenotype on plate. In frame deletion pel and psl mutants were
engineered in the PAO1 and PprBK genetic backgrounds and
examined as well. It appears that whilst Psl mainly impacts PAO1
biofilm (Fig. 4B, p,0.001), Pel has a non significant impact as
described earlier [36]. The hyper biofilm of PprBK strain was
unmodified in the corresponding pel and psl mutants as compared
to their isogenic parental strain PprBK, strongly reinforcing the
idea that once the PprBK signaling pathway is activated, the hyper
biofilm observed does not rely on Pel and Psl exopolysaccharides
(Fig. 4B illustrates the different crystal violet stained biofilms and
corresponding quantitative analysis). Since we observed a signif-
icant induction of pqs genes that have been previously reported to
control exogeneous DNA release (eDNA) [37], we further looked
at the presence of eDNA in the observed PprBK-dependent hyper-
biofilm. Indeed, eDNA was substantially present in the PprBK
biofilm as compared to the PAO1 one, in particular in lower layers
(Fig. 4C, upper panel), forming meshing (Fig.4C, upper panel,
enlarged view). A DDAO staining was additionally performed, this
probe being recognized for its affinity for double stranded DNA,
good fluorescence properties, molecular size preventing it from
penetrating intact membranes and therefore targeting only eDNA
[37,38]. Bacterial aggregates within the PprBK formed - biofilms
displayed a positive DDAO staining while those of PAO1 formed
– biofilms were slightly stained (Fig. 4C, lower panel). Taken
together, these results highly suggest that eDNA release plays a
very important role in shaping the PprBK hyper-biofilm pheno-
type, whilst at the same time Psl or Pel EPS are useless.
To further assess the capacity of PprBK to form biofilms in vivo
and the contribution of BapA in this process, flies were orally
infected with PAO1, PprBK and PprBKDbapA strains. In all three
cases, one day following infection, large amounts of bacteria were
found in the crop lumen (shown for PAO1 in Fig. S5) and in the
proventriculus (PV) (Fig. S6). Additionally, PprBK infected guts
displayed dense bacterial aggregates located along the Drosophila
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Figure 3. PprB-dependent phenotypes. Biofilm formation monitored at day 1 (J1) and 4 (J4) of PAO1GFP and PprBKGFP strains (A). Antimicrobial
tolerance of PAO1 GFP and PprBKGFP -5day aged biofilms exposed to 20 mg/ml of tobramycin for 24 hr (B). Dead cells were labeled with propidium
iodide. Extracted z images and their respective xy and xz planes are presented. Resazurin viability test was performed in PAO1 and PprBK biofilms
formed in microplates and exposed to 20 mg/ml of tobramycin for 24 hr. Relative fluorescence (RFU) was measured using lexc and lem of 530 nm and
595 nm, respectively. Independent measurements were submitted to a one way statistical test (*:,0.05). PprBK strain virulence was examined in D.
melanogaster model (C) using fast killing assay and compared to PAO1. Survival curves (% of live flies according to time of infection) were drawn and
each point represents a total of 30 flies displayed in 3 different vials by group of 10. One representative experiment out of three is shown. PprBK
strain virulence (D) was tested in the HeLa cell model (right and upper panel) and compared to the PAO1 strain. Rounding of cells was surveyed
under optical microscopic observation. Cytotoxicity of PAO1 and PprBK strains towards J774 murine macrophages was evaluated by LDH release
measured at OD490 (Left panel). Statistical differences were evaluated using a t-test (*:,0.05, **:,0.0.01, ***:,0.001). In vitro secretion of T3SS
proteins forming the translocon (PopB, PopD and PcrV) was checked with (+) or without (2) inducing conditions (EGTA) in PprBK and PAO1 strains
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epithelium in the anterior midgut (AMG) (Fig. 5A and B) mostly
surrounded with extracellular DNA (see arrowheads in Fig. 5B)
and which are likely to correspond to in vivo biofilms. In contrast,
bacteria were found mostly dispersed in PprBKDbapA (Fig. 5C and
D) and PAO1 infected flies (Fig. 5E and F). PprBK and PAO1 cells
were found in close contact with the intestinal barrier (Fig. S6C
and Fig. S5C respectively). Of note, bacterial aggregates were
observed not only in the crop as previously reported [24], but also
in various parts of the intestinal tract such as the anterior midgut
(AMG) (Fig. 5) and the proventriculus (PV) (Fig. S6). Although,
sometimes massively present in the lumen gut (not shown), the
PprBKDbapA strain was found to be strongly impaired in its
(right and lower panel). Bacterial virulence was checked in D. melanogaster oral infection assay (E) for PprBK, PprBKDbapA and PAO1 strains. Survival
curves (% of live flies according to time of infection) were drawn and each point represents a total of 60 flies. One representative experiment out of
three is shown. Dissemination of bacteria from the gut lumen toward the hemolymph compartment (F) was evaluated for PprBK, PprBKDbapA and
PAO1 strains by counting CFU in hemolymph collected and pooled from 10 infected Drosophila per strain. Box plots represent the data obtained on 3
independent experiments made for each strain. Statistical differences were evaluated using a Kruskal-Wallis One Way Analysis (*:,0.05).
doi:10.1371/journal.ppat.1003052.g003
Figure 4. Contribution of PprB-dependent biofilm matrix in biofilm structuration. Biofilm formation monitored under dynamic conditions
(A) at day 4 of PprBKGFP, PprBKDbapAGFP, PprBKDbapDGFP, PprBKDcupE5GFP, PprBKDflpGFP, and PprBKDcupE5DbapADflpGFP strains. Crystal violet (CV) -
stained biofilms (B) formed by PprBK (wt), PprBKDpel (pel mutant), PprBKDpsl (psl mutant), PAO1 (wt), PAO1Dpel (pel mutant) and PAO1Dpsl (pel
mutant) strains (tube views, left panel). CV staining was extracted and quantitative analysis was performed. Data presented represent means values
and standard deviations obtained at least 4 independent experiments (right panel). Upper panel: biofilm formation monitored under dynamic
conditions (C) at day 4 of PAO1GFP and PprBKGFP strains in which eDNA was revealed using propidium iodide (red labeling) in intermediate (plain
arrows) (left images) and low (dotted arrows) projections (right images). Extracted z images and their respective xy and xz planes are presented.
Enlarged view of the meshing formed by the eDNA present at the base of the PprBK biofilm. Lower panel: biofilm formation monitored under static
conditions (C) at day 4 of PAO1GFP and PprBKGFP strains in which eDNA was revealed using DDAO probe (red labeling). Combined transmitted and
green (left images) and combined transmitted and red (left images) images were shown.
doi:10.1371/journal.ppat.1003052.g004
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capability to either stick to Drosophila epithelial tissues or to
disseminate towards the hemolymph compartment (Fig. 3F).
Instead, PprBKDbapA bacteria were taking part to a long sticky
viscous filament observed upon dissection probably cemented by
extracellular material and/or adhesive properties of bacterial cells
themselves (data not shown).
Taken together, these observations indicate that PprBK forms
biofilm on the mucosal surface in the midgut compartment a
phenomenon requiring the BapA adhesin, while it is impeded in
dissemination independently of BapA.
Discussion
In the present study we unraveled the genes belonging to the P.
aeruginosa TCS PprAB regulon among which we identified a
particular association of molecular actors involved in biofilm
formation. We identified BapA, a large cell surface and T1SS
secreted protein. BapA is the first member in P. aeruginosa of a
family of large proteins involved in adhesion and biofilm formation
extensively growing in Gram positive and Gram negative bacteria.
They all exhibit substantial sequence identity with expansive
domains with imperfect tandem repeats of 86–106 amino acids,
and are strikingly large, cell surface-localized and/or secreted
proteins. In Gram–negative bacteria, they all share a T1SS
mechanism, through a transporter possessing ABC characteristics
generally closely associated in an operon together with their
respective substrates. Evidence has been provided that this kind of
secreted proteins promotes multicellular cell-to-cell interactions,
however whether they form filamentous structures and presump-
tive calcium-binding domains influence the adhesive and cohesive
processes remain to be answered [35]. BapA from P. aeruginosa is
indeed secreted by the T1SS transporter encoded by the adjacent
bapBCD genes and possesses the GGDGSD T1SS sequence
consistent with the observed instability of the substrate in the
absence of its cognate BapBCD transporter. This sustained a
strong coupling between BapA synthesis and BapBCD-dependent
secretion, as previously reported [39]. BapA forms with CupE
fimbriae from the CU family and Type IVb pili, a molecular
toolkit in which all cooperate to shape biofilm development as it
has been reported for BapA in S. enteritica with cellulose and curli
fimbriae upon the common regulation of csgD. CsgD – dependent
direct and positive expression of csgBA and adrA genes encoding
cellulose and curli fimbriae [40] has been coupled to bapA gene
induction [33,34] in S. typhimurium. Thus, as for CsgD in S.
Figure 5. Confocal sections of Drosophila anterior midguts (AMG). Flies were orally infected with GFP expressing bacteria (green); guts were
dissected at one day post-infection and stained with Alexa 546-phalloidin (actin, red) and DAPI (DNA, blue). Sections of PprBKGFP (A), PprBKDbapAGFP
(C) and PAO1GFP (E) infected anterior midguts. Magnifications of corresponding indicated squares (PprBKGFP (B), PprBKDbapAGFP (D) and PAO1GFP
(F)). Particular high density area of PprBKGFP bacteria surrounded with eDNA (arrowheads) (B) was shown.
doi:10.1371/journal.ppat.1003052.g005
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typhimurium, the PprB regulator may represent a checkpoint of
multicellular and aggregative behavior in P. aeruginosa [41]. This
renders BapA protein from P. aeruginosa closer to BapA from S.
typhimurium rather than to Lap proteins of the pseudomonads. Lap
protein regulation has been described to be controlled by c-di-
GMP intracellular messenger through proteins encoded by genes
close to their respective targets, such as LapD for LapA, a protein
with degenerate GGDEF and EAL motifs [42] and probably
PP_0798 encoded protein, a GGDEF-type protein for LapF.
There is a gene encoding a GGDEF protein PA1851 in the vicinity
of P. aeruginosa bapA gene (PA1874). However, its overexpression or
deletion did not lead to a particular biofilm phenotype in the PA14
strain, suggesting that it is probably not involved in controlling
bapA regulation in P. aeruginosa [43]. We cannot exclude that it may
occur in the PAO1 genetic background or in the PprB activated
context, even though this particular gene is not regulated by PprB.
Whether P. aeruginosa BapA acts through homophilic interactions
such as the S. enteritica BapA protein [33], or whether, it
participates to physical association with CupE fimbriae or/and
Type IVb pili in the biofilm as it has been reported for the P.
aeruginosa CdrA protein (a two partner secretion or Type Vb large
substrate) with Psl extracellular polysaccharide matrix [44]
remains to be elucidated. Interestingly, BapA adhesin appears to
be a major determinant in biofilm establishment and attachment
on the mucosal surface of the midgut observed in orally infected
Drosophila. Indeed PprBDbapA was incapable to stick to Drosophila
epithelial tissues and was strictly restricted to the lumen of the gut
while it still possesses an aggregative behavior in various gut
compartments (crop, proventriculus). This contrasts with the
strong attenuation of in vitro biofilm in the bapA mutant as
compared to the PprBK parental isogenic strain, suggesting that
there is probably beside the bacterial produced matrix, Drosophila
material that could also interfere with the remaining bacterial cell
structures, in particular Type IVb pili and/or CupE CU fimbriae.
In this particular extracellular matrix produced upon the PprB
activation, eDNA release through probable PQS regulatory
pathway activation is also playing a key role in shaping the
community and therefore contributes to multi-cellular develop-
ment processes as previously reported [37]. DNA cement was also
observed in the chronic Drosophila model used here. The
involvement of PQS in DNA release [37] has been reported
earlier and strongly contributes to the formation of huge
mushroom-shaped structures [45]. pqsA expression specifically
occurs in microcolonies in the early phases of biofilm formation
[37] and reaches a maximum level in 2-day-old biofilms [45].
Moreover this particular time and location expression is critical for
cap formation [45]. Here, eDNA that mainly localized in cell
layers in contact with the substratum, is thus a cell-to-cell
interconnecting matrix component in PprBK biofilm that
contributes together with Type IVb pili, fimbriae of the CU
pathway and BapA protein to the hyper-biofilm phenotype of this
strain. From the present study, we highlighted a hyper-biofilm
phenotype without major involvement of EPSs as undoubtedly
proved with unaltered hyper-biofilm phenotype of the pel and psl
mutants in the PprBK genetic background such as those previously
reported in P. aeruginosa. This very interesting and new feature has
been already observed for Rhizobium which is able to form
biofilms on roots of non-legumes, independently of EPS synthesis
[46], thus reinforcing the notion that EPS is not an absolute
marker of biofilm lifestyle.
Beside this hyper-biofilm phenotype associated with PprAB
activation, we observed a decreased T3SS secretion in the PprBK
strain as compared to the PAO1 strain associated with a reduced
cytotoxicity in epithelial and macrophage lineages. This matches
with the idea that biofilm is regulated in an opposite way from
cytotoxic-mediated and T3SS-dependent virulence as demonstrat-
ed for many pathways in particular those involving small
regulatory RNAs RsmY and RsmZ [47]. This probably occurs
through PQS level, which high level is negatively influencing
T3SS effector secretion [48]. Decreased T3SS expression (Table
S2) may also account for decreased virulence in acute Drosophila
model of infection in which T3SS is known to play a major
function [5]. Interestingly, our P. aeruginosa hyper-biofilm strain
showed reduced virulence in both acute and chronic Drosophila
infection similarly to what was described for the hyper-biofilm
PAZH strain [24]. As previously observed in the case of PAZH
(Mulcahy et al., 2011), decreased virulence of PprBK is tightly
associated with its incapability to cross the intestinal barrier and to
reach the hemolymph. However, in contrast to PAZH, biofilms
formed by PprBK were found not only in the crop but also in
various parts of the intestinal tract including the proventriculus
and the midgut.
In the present study, we also unraveled the PprB-dependent
activation of the hvnA gene encoding a putative ADP-ribosylating
toxin that has never been identified so far in this bacterium. No
HvnA-dependent virulence phenotype could be observed in a first
round of assays, suggesting that either HvnA targets other host
proteins than do ExoS and ExoT ARTases, or that host proteins
targeted by this protein are not present in the D. melanogaster model.
Even if HvnA is translated (detected in bacterial crude extracts,
data not shown), there is no evidence yet of its secretion. HvnA
displays a high identity in its N-terminal domain with the
halovibrin from V. fischeri which has been initially thought to
catalyze polyarginine ribosylation using NAD1 as a substrate [49],
but also polylysine and polyhistidine ADP-ribosylation thus
releasing free, reactive, ADP-ribose through a NAD+-glycohy-
drolase activity (NADase) [29]. Clinical streptococcal isolates and
V. cholerae secrete NADases [50,51], which observation combined
with our results, may initiate further study of the role of secreted
NADases in bacterium-host interactions.
An original observation made in the present study is the
association of a hyper-biofilm phenotype with an increased
susceptibility to tobramycin, whereas biofilm lifestyle has been
extensively associated with resistance to antibiotics. In contrast
with a previous study [28], suppression of BapBCD transporter
showed no influence on tobramycin susceptibility (Table S3). Our
results would thus indicate that the increased susceptibility to
tobramycin in biofilm is probably due to the particular nature of
the matrix exopolymer sealing the community and/or to the
increased membrane permeability linked to PprB [20]. Drug
susceptibility could also be explained by the PprB-dependent
repression of the mexXY operon that encodes part of the tripartite
multidrug efflux pump MexXY-OprM (Table S1). This hypothesis
was ruled out by the absence of PprB-dependent change in the
level of mexXY mRNA assessed by RT-qPCR (data not shown), as
well as by the observation of equal drug resistance of a mexXY
mutant under activated - or inactivated - PprB pathway
conditions. This later experiment further ruled out other
mechanisms and in particular those implicating ribosomal targets.
Additionally and very interestingly, an increased susceptibility to
aminosides has been linked to elevated intracellular polyamine
levels. In E. coli, the ammonium transporter AmtB is thought to
import ammonia and to lead to increased intracellular level of
polyamines [52], these latter having been shown to increase
translation of OppA, a periplasmic binding protein involved in
aminoglycoside uptake [53]. This was a very seductive aspect to
mention since in our study, the amtB gene has been shown to be
differentially regulated in our transcriptomic study. While the glnK-
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amtB operon was potentially interesting for further drug suscep-
tibility phenotype interpretation, we were unable to observe any
change in amtB transcription activity or quantities of amtB mRNA
upon PprB activation by RT-qPCR. Thus the particular matrix
surrounding PprB-activated biofilm could be the major determi-
nant of associated increased susceptibility to tobramycin, a
hypothesis which would deserve further investigation.
Finally, this work demonstrates that the TCS PprAB in P.
aeruginosa may represent a key bacterial adaptation checkpoint of
multicellular and aggregative behavior combining a particular
adhesive signature, associating increased drug susceptibility and
decreased virulence, a particular interesting therapeutic window to
consider in eradication of P. aeruginosa biofilm-associated infections.
Even though we studied a particular regulatory pathway
(artificially activated in PprBK strain), recent data were obtained
in early CF strains that showed that this PprB pathway is activated
in humans [54] and reinforcing the idea that there could be timing




Bacterial strains, growth conditions, deletion mutants and
chromosomal fusions are described in the supplemental experi-
mental procedures (Tables S4, S5, S6). The expression of the
different transcriptional fusions was monitored by assaying ß-
galactosidase activity as previously described [23].
EMSAs
Electrophoretic mobility shift assays (EMSAs) were performed
as follows. 329 bp, 630 bp, 612 bp, 348 bp DNA regions of the
bapA, hvnA, pqsA, PA3662 putative promoters were amplified by
PCR using the appropriate oligonucleotide pairs (Table S6) in the
presence of aP32 dGTP. A mixture of each PCR product (50 ng)
and of sonicated salmon sperm DNA (2 mg/ml, ratio 1:40 of the
different promoters and the competitor DNA) in a 50 mM Tris-
HCl buffer pH 8.2 supplemented with 1 mM EDTA and
0.25 mM saccharose, was incubated for 30 min at room
temperature with various concentrations of purified PprB-6His
protein ranging from 0 to 2.34 mM. Samples were resolved on a
pre-run 12%-acrylamide gel in Tris-borate buffer. Gels were fixed
in 10% trichloro-acetic acid for 10 min, and exposed to Kodak
BioMax MR films.
Cell fractionation and supernatant preparation
Bacterial cells were harvested, resuspended in Tris HCl 10 mM
pH 8.0 with protease inhibitor cocktail, and disrupted. To remove
unbroken cells additional centrifugation at 5,000 rpm was done
before ultracentifugation for 30 min at 45,000 rpm. Upper soluble
phase fraction contains both cytoplasmic and periplasmic
fractions, whereas the pellet contains membranes. Supernatants
S1 and S2 were collected as previously described [30]. Cell
extracts and supernatants were loaded at 0.1 OD600 unit for total
cell extracts, 0.1 OD600 unit for soluble (cytoplasmic and
periplasmic fractions) fractions, 0.5 OD600 unit for membrane
(M) fractions, 1 OD600 unit for classical (S1) and associated loosely
with the cell surface (S2) supernatants. Proteins were separated by
electrophoresis in an 8% polyacrylamide gel. BapA protein was
immunodetected with the polyclonal antibodies against BapA
(1:1,000, (produced as described in the supplemental experimental
procedures) and leakage was followed by immunodetection of the
cytoplasmic ornithine carbamoyltransferase (OTCase) protein
using a specific antibody (a gift from Dieter Haas, Universite´ de
Lausanne, Switzerland) at a dilution of 1:500.
Biofilm formation
Time-lapse biofilm formation was performed in flow chambers
as described previously [23]. The P. aeruginosa strains were tagged
with green fluorescent protein (GFP), as described elsewhere [55].
Observation was performed with an Olympus FV-1000 micro-
scope equipped with detectors and filter sets for monitoring of
GFP, propidium iodide. The flow cell inoculation, the running of
the system, the microscopic inspection, the image capture and the
analysis were carried out as previously described [56]. The pel and
psl mutants were grown in parallel to their isogenic parental strains
under static conditions at 30uC and attached bacteria were stained
with 1% Crystal Violet. Staining was extracted by treatment with
400 ml 95% ethanol. Subsequently, 600 ml of water was added and
OD570 was measured. All quantification assays were made at least
in triplicate. eDNA staining was performed using a combination of
fluorescent probes including propidium iodide and DDAO as
previously reported [38] and observed with appropriate filters.
Transcriptional profiling using microarrays
Cells were grown in LB for 8 hr at 37uC in the presence of
10 mM of IPTG when strains carried plasmids. RNAs were
prepared using the Midiprep Total RNA Isolation System
(Promega). The integrity of RNA preparations was checked by
the Experion automated electrophoresis system (Bio-Rad) and the
absence of DNA contamination was verified by PCR. 500 ng of
RNA were further processed for double Cy3/Cy5 labelling using
the MessageAmp II aRNA Amplification Kit (Ambion). Dye
incorporation rates were measured using a Nanodrop ND-1000
spectrophotometer (Nanodrop technologies Wilmington, DE).
300 ng of Cy3-labelled and of Cy-5 labelled aRNA mixtures were
hybridized for 17 hr at 65uC according to Agilent protocols on the
MGPA DNA Chips. MGPA chips and data analysis are described
in supplemental experimental procedures.
Drosophila acute and chronic infections
Flies infections were performed using diluted bacterial expo-
nential phase cultures (0.5 OD600 nm) as described previously
[5,26,57]. 30 and 60 w118 (control genotype) males were infected in
each experiment for septic and oral infections respectively and
distributed ten by ten into vials. One experiment out of three is
shown. Additionally, calibrated drops of hemolymph were
sampled from 10 infected flies per bacterial strain, diluted in
100 ml of LB and serial dilutions were further plated on PIA.
Colony-forming units (CFU) were numbered after overnight
incubation at 37uC.
Drosophila guts staining
Guts from infected Drosophila were dissected in PBS 24 hr
following oral infection and fixed for 40 min in 4% paraformal-
dehyde. After twice rinsing in PBS, samples were incubated
overnight at 4uC in 2 U/ml Alexa Fluor 546 Phalloidin
(Invitrogen). After mounting in DAPI containing Vectashield
(Vector Laboratories, H-1200), the samples were imaged with a
406or 636magnification (oil immersion) using a Leica TCS SP2
confocal microscope and the LCS software. A total of at least 5
dissected intestines per experiment which have been reproduced
three times were performed.
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HeLa cell, J774 murine macrophage infection and T3SS
secretion
T3SS-dependent cytotoxicity was evaluated on cultured epithe-
lial HeLa cells and J774 murine macrophages [58]. Cytotoxicity
was evaluated on J774 cells by measuring LDH release using
Cytotoxicity Detection kit (Roch) after 1, 2 and 3 hr of contact
with bacteria at a MOI of 10. Images of infected HeLa cells were
obtained at 3 hr post-infection using Leica DM IRE2 microscope.
Induction of T3SS in vitro was obtained by adding 5 mM EGTA
and 20 mM MgCl2 to bacterial cultures at OD600 nm of 0.1. After
3 hr of growth at 37uC with agitation, supernatants were collected
and analyzed by immunoblot using anti-PcrV, anti-PopB, anti-
PopD polyclonal antibodies [58].
Antibiotic susceptibility
The minimal inhibitory concentrations (MICs) of tobramycin
and ciprofloxacin were determined as recommended by the CLSI
by the dilution method in Mueller Hinton agar [59]. The minimal
bactericidal concentrations for biofilm (MBC-B) and planktonic
cells (MBC-P) were determined as previously described [28].
Additionally, susceptibility towards tobramycin was further
checked in flow cell experiments. At day 4, biofilms formed by
PAO1 and PprBK strains in flow cell chambers were exposed to
20 mg/ml of tobramycin for 24 hr at 30uC. Dead cells were
revealed by additional propidium iodide exposure for 10 min and
resulting red cell populations were observed using appropriate
filter.
Supporting Information
Figure S1 Schematic diagram of the flprcptad and cupE loci and
the six new loci gathering the 35 genes identified as differentially
regulated by the RR PprB. The PprB-controlled genes identified
in the microarray experiments are grayed. Numbers on the right
side refer to the size of the corresponding DNA regions in kilobases
(kb).
(TIF)
Figure S2 Expression of the chromosomal hvnA-lacZ (A) PA1215-
lacZ (B), PA1221-lacZ (C), glnK-lacZ (D) fusions was monitored in
the PAO1/pMMB67HE (black circles) and PAO1/pMMBpprB
(open circles) strains grown for 8 hr in the presence of 10 mM
IPTG. Data are expressed in Miller units and correspond to mean
values (with error bars) obtained from three independent
experiments. The corresponding growth curves (dotted curves)
are presented.
(TIF)
Figure S3 HvnA protein from P. aeruginosa is 408 aa polypeptide
(A) with a signal peptide (aa 1–24), a HvnA domain (aa 25–301)
with an RGD sequence at position 174 and C-terminal DUF2599
domain (aa 302–408). ClustalW alignment of the halovibrin
domain of HvnA from P. aeruginosa with HvnA of V. fischeri (regions
I, II and III, the region III constituting the active site for NAD+
hydrolysis are squared and RGD sequence is underlined). PAO1
and PAO1DhvnA strains were examined for virulence in D.
melanogaster model (B) using fast killing assay. Survival curves (% of
live flies according to time of infection) were drawn and each point
represents a total of 30 to 50 flies. One representative experiment
out of three is shown.
(TIF)
Figure S4 Genetic organization (A, Upper panel) of the P.
aeruginosa bapABCD locus. Above is the precise localization of
primers used to target each contiguous gene junction (see Table
S6) for determination of operonic structure along the locus.
Corresponding bands (A, Lower panel) with expected size
obtained after PCR on genomic DNA were compared to the
ones obtained after RT-PCR on RNA (cDNA). Absence of DNA
contamination of RNA was controlled. DNA ladder and sizes in
bp are precised on the left. Analysis of BapA sequences (B) from
PA14, LESB58, C3719, 39016 and PA7 strains performed using
Xstream and compared to the BapA sequence from PAO1 strain.
Deletions were observed in Domain 1 for 39016 (D12/D13) and
PA7 (D12) strains. In Domain 2, insertions of repeats D216S1/
D216S2/D216S3 in PA14 and LESB58 strains, D214S1 and
D215S1/D215S2 in PA7 strain and deletions of D216 for C3719
strain and D24/D25/D26 for 39016 strain were observed.
Polymorphism raises 22% for BapA from PA7 strain as compared
to PAO1 strain.
(TIF)
Figure S5 PAO1GFP infected Drosophila guts. Flies were orally
infected with GFP expressing PAO1 strain (green); guts were
dissected at one day post-infection and stained with Alexa 546-
phalloidin (actin, red) and DAPI (DNA, blue). Confocal sections
(A) of anterior part of the gut showed bacterial high density area in
the crop and proventriculus (PV). Magnifications (B, C) of
indicated square showed high density bacteria sticking along the
Drosophila epithelium.
(TIF)
Figure S6 Confocal sections of Drosophila infected proventric-
ulus. Flies were orally infected with GFP expressing bacteria
(green); guts were dissected at one day post-infection and stained
with Alexa 546-phalloidin (actin, red) and DAPI (DNA, blue).
PAO1GFP (A, B), PprBKGFP (C, D) and PprBKDbapAGFP (E, F).
Entire views of the proventriculus (PV) (A, C, E); magnifications
of indicated squares show bacteria accumulating in the lumen
(B, C, F). Arrow shows dense bacterial aggregates which
are likely to correspond to in vivo biofilms in the case of PprBK
(C).
(TIF)
Figure S7 The PprB-6His version used for EMSA has been
checked to be able to complement a pprB mutant for PprB-
dependent expression of the reporter fusions cupE–lacZ (A) and flp–
lacZ (B) and PprB-dependent CupE1 (A) and Flp (B) production.
Number on left side is molecular weight standard (kDa).
(TIF)
Table S1 Genes differentially expressed in Experiment 1
comparing PAO1attB::cupE-lacZ/pMMBpprB strain vs PAO1attB::-
cupE-lacZ/pMMB67HE strain.
(DOC)
Table S2 Genes differentially expressed in Experiment 2
comparing PAO1attB::cupE-lacZ strain vs PAO1DpprB attB::cupE-
lacZ strain.
(DOC)
Table S3 Antibiotic susceptibility of P. aeruginosa strains. a The
data presented have been obtained on five distinct and
independent experiments and MIC, MBC-P (minimal bactericidal
concentrations for planktonic cells) or MBC-B (minimal bacteri-
cidal concentrations for biofilm cells) values were found to be
strictly identical in the five different experiments.
(DOC)
Table S4 Strains used in this study. *SmR, streptomycin
resistance, ApR, ampicillin resistance, KmR, kanamycin resistance,
GmR gentamicin resistance, TcR tetracycline resistance.
(DOC)
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Table S5 Plasmids used in this study. *SmR, streptomycin
resistance; ApR, ampicillin resistance; KmR, kanamycin resistance;
GmR gentamicin resistance; TcR tetracycline resistance.
(DOC)
Table S6 Oligonucleotides used for mutagenesis and gene
cloning.
(DOC)
Text S1 Supplemental experimental procedures.
(DOC)
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